DJIA 16,654.77 369.26 2.27%
NASDAQ 4,812.71 115.17 2.45%
S&P 500 1,987.66 47.15 2.43%
market minute promo

Gilead Sciences (NASDAQ: GILD)

107.99 1.03 (0.96%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $107.99 0.96%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $108.43
Previous Close $106.96
Daily Range $105.67 - $109.60
52-Week Range $85.95 - $123.37
Market Cap $158.5B
P/E Ratio 11.25
Dividend (Yield) $1.72 (1.6%)
Ex-Dividend Date
Dividend Pay Date
09/14/15
09/29/15
Volume 14,585,380
Average Daily Volume 10,893,890
Current FY EPS $11.99

Sector

Healthcare

Industry

Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary Rss Feed

Bouncing Biotech? 3 Stocks To Buy

It may be time to consider buying Gilead Sciences, Celgene Corp, and Regeneron on sale.

Benzinga's M&A Chatter for Thursday August 27, 2015

12 Attractive Fast-Growing Dividend Growth Stocks for High Total Return

12 Attractive Fast-Growing Dividend Growth Stocks For High Total Return

Biogen And Gilead Sciences Catch The Eye Of Short Sellers

What To Buy Now

J&J to Sell Sugar Substitute Splenda to Heartland Food

Novartis' (NVS) Promacta Label Further Expanded in U.S.

Results From the AMBITION Study of First-Line Treatment With Letairis and Tadalafil in Pulmonary Art

Results From the AMBITION Study of First-Line Treatment With Letairis and Tadalafil in Pulmonary Arterial Hypertension Published in The New England Journal of Medicine

Short Sellers Become More Focused in Major Biotechs

The Worst Is Over, 5 Reasons To Get Ready For A 'V' Shaped Rally

See More GILD News...

GILD's Top Competitors

GILD $107.99 (0.96%)
Current stock: GILD
AMGN $155.72 (1.13%)
Current stock: AMGN
CELG $123.04 (3.20%)
Current stock: CELG
$0.00 (0.00%)
Current stock: